491 related articles for article (PubMed ID: 18613460)
1. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D
Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460
[TBL] [Abstract][Full Text] [Related]
2. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
3. Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.
Manojlovic N; Nikolic L; Pilcevic D; Josifovski J; Babic D
Hepatogastroenterology; 2004; 51(55):282-4. PubMed ID: 15011886
[TBL] [Abstract][Full Text] [Related]
4. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
5. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
6. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
Atalay C; Atalay G; Altinok M
Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851
[TBL] [Abstract][Full Text] [Related]
7. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
8. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
9. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
[TBL] [Abstract][Full Text] [Related]
10. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
[TBL] [Abstract][Full Text] [Related]
11. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
[TBL] [Abstract][Full Text] [Related]
12. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
[TBL] [Abstract][Full Text] [Related]
13. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
[TBL] [Abstract][Full Text] [Related]
14. Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma.
Ren Z; Borody T; Pang G; Li LC; Dunkley M; Clancy R
J Gastroenterol Hepatol; 2005 Sep; 20(9):1338-43. PubMed ID: 16105118
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of IgG antibody titer against Helicobacter pylori.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T
FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215
[TBL] [Abstract][Full Text] [Related]
20. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
